Masimo
MASI
NZ$271.05
Share price
-2.00%
Change (1 day)
48.27%
Change (1 year)
Categories
Masimo is an American manufacturer of noninvasive patient monitoring technologies based in Irvine, California.
Masimo (MASI) - Total debt
Total debt on the balance sheet as of March 2025 : NZ$1.13 Billion
According to Masimo's latest financial reports the company's total debt is NZ$1.13 Billion. A company’s total debt is the sum of all current and non-current debts.
Masimo - Total debt on balance sheet (from 2005 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$1.50 B | -2.19% |
| 2023-12-31 | NZ$1.53 B | -5.34% |
| 2022-12-31 | NZ$1.62 B | 3284.74% |
| 2021-12-31 | NZ$47.87 M | 0.57% |
| 2020-12-31 | NZ$47.6 M | 56.49% |
| 2019-12-31 | NZ$30.41 M | |
| 2018-12-31 | N/A | |
| 2017-12-31 | N/A | -100% |
| 2016-12-31 | NZ$0.1 M | -99.96% |
| 2015-12-31 | NZ$0.27 B | 69.26% |
| 2014-12-31 | NZ$0.15 B | 7653.04% |
| 2013-12-31 | NZ$2.06 M | -18.94% |
| 2012-12-31 | NZ$2.54 M | 1526.83% |
| 2011-12-31 | NZ$0.15 M | -29.89% |
| 2010-12-31 | NZ$0.22 M | -29.9% |
| 2009-12-31 | NZ$0.31 M | -70.33% |
| 2008-12-31 | NZ$1.07 M | -97.36% |
| 2007-12-31 | NZ$40.52 M | 35.68% |
| 2006-12-31 | NZ$29.86 M | -29.75% |
| 2005-12-31 | NZ$42.51 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ResMed RMD | NZ$1.39 B | 23.22% | 🇺🇸 USA |
 Philips PHG | NZ$13.61 B | 1,101.59% | 🇳🇱 Netherlands |
 Thermo Fisher Scientific TMO | NZ$56.85 B | 4,916.73% | 🇺🇸 USA |
 Universal Forest Products
UFPI | NZ$0.59 B | -47.43% | 🇺🇸 USA |
 Cardinal Health CAH | NZ$12.77 B | 1,026.78% | 🇺🇸 USA |
 General Electric GE | NZ$32.54 B | 2,771.75% | 🇺🇸 USA |
 Owens & Minor
OMI | NZ$3.77 B | 233.31% | 🇺🇸 USA |
 CONMED CNMD | NZ$1.48 B | 30.91% | 🇺🇸 USA |